01-11-2020 | Rituximab | Correction
Correction to: Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities
Published in: Annals of Hematology | Issue 11/2020
Login to get access